Barco introduced two medical-grade reviewing and conferencing projection systems Sunday at the RSNA meeting, adding to its line of large-screen imaging displays.
Barco introduced two medical-grade reviewing and conferencing projection systems Sunday at the RSNA meeting, adding to its line of large-screen imaging displays.
DICOM Theater Lite, a lightweight portable system, provides 1400 x 1050-pixel Super XGA+ resolution, 2000:1 contrast, 2000-lumen light output, and silent operation. Fully compliant with DICOM quality standards for image accuracy, Theater Lite can be connected to PACS workstations seamlessly via the BarcoMed display controller.
DICOM Theater Pro, the company's premier medical projection system, can display images from several sources using a single projector. It features an MGP 15 projector, a dedicated BarcoMed display controller, MediCal Pro QA software, and Barco's I-Guard sensors. Because of its integrated smart dual lamp design and high-resolution Poly-SI LCT technology, Theater Pro projects images with a 4500-lumen brightness.
MediCal Pro QA works with commercially available sensors as well as the I-Guard to maintain conformity and consistency of single color, gray-scale, CRT, or liquid crystal displays. The I-Guard feature stabilizes the projection of continuous images and adds DICOM compatibility.
All DICOM Theater projection systems are suitable for use with PACS as well as other source images, including computer data, endoscopy, and ultrasound.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.